Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Fluocinolone acetonide SR by EyePoint Pharmaceuticals for Retinopathy: Likelihood of Approval
Fluocinolone acetonide SR is under clinical development by EyePoint Pharmaceuticals and currently in Phase III for Retinopathy. According to GlobalData,...